Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1.
about
Moyamoya Syndrome: A Window of Moyamoya DiseaseAlternative splicing of the neurofibromatosis type I pre-mRNAA new horizon of moyamoya disease and associated health risks explored through RNF213Moyamoya disease and syndromes: from genetics to clinical managementHyperactivation of p21ras and PI3K cooperate to alter murine and human neurofibromatosis type 1-haploinsufficient osteoclast functionsCerebrovascular stenosis in neurofibromatosis type 1 and utility of magnetic resonance angiography: our experience and literature review.[Type I neurofibromatosis and megadolichobasilar artery]Hemorrhagic onset of pilocytic astrocytoma and pilomyxoid astrocytoma.Genetic and cellular evidence of vascular inflammation in neurofibromin-deficient mice and humans.Neurofibromatosis type 1 is not associated with subarachnoid haemorrhage.Moyamoya syndrome and neurofibromatosis type 1RNF213 rare variants in an ethnically diverse population with Moyamoya disease.Extracranial vertebral artery involvement in neurofibromatosis type I. Report of four cases and literature review.Cranial irradiation increases risk of stroke in pediatric brain tumor survivors.Spectrum and prevalence of vasculopathy in pediatric neurofibromatosis type 1.Racial/Ethnic Differences in Pediatric Brain Tumor Diagnoses in Patients with Neurofibromatosis Type 1.Update on the management of familial central nervous system tumor syndromes.Monogenic vessel diseases related to ischemic stroke: a clinical approach.Neurofibromatosis type 1 in genetic counseling practice: recommendations of the National Society of Genetic Counselors.Childhood arterial ischemic stroke: a review of etiologies, antithrombotic treatments, prognostic factors, and priorities for future research.Cerebral arteriopathy in neurofibromatosis type 1.Characteristics of children enrolled in treatment trials for NF1-related plexiform neurofibromas.Cerebrovascular disease in childhood cancer survivors: A Children's Oncology Group Report.Giant thrombosed intracavernous carotid artery aneurysm presenting as Tolosa-Hunt syndrome in a patient harboring a new pathogenic neurofibromatosis type 1 mutation: a case report and review of the literature.Childhood and teenage stroke.A Review of the Genetics of Intracranial Berry Aneurysms and Implications for Genetic Counseling.Neurofibromin-deficient myeloid cells are critical mediators of aneurysm formation in vivo.Genetic variants promoting smooth muscle cell proliferation can result in diffuse and diverse vascular diseases: evidence for a hyperplastic vasculomyopathy.Clinical features and long-term follow-up of quasi-moyamoya disease in children.Neurovascular manifestations of connective-tissue diseases: A review.Intracranial and extracranial fusiform aneurysms in a patient with neurofibromatosis type 1: a case report.Genetic and Epigenetic Regulation of Aortic AneurysmsNeurofibromin is a novel regulator of Ras-induced reactive oxygen species production in mice and humans.Giant extracranial aneurysms of both internal carotid arteries with aberrant jugular veins in a patient with neurofibromatosis type 1.Prevalence of Intracranial Aneurysms in Patients with Connective Tissue Diseases: A Retrospective Study.Neurofibromatosis type 1 association with moyamoya disease.Endovascular treatment of basilar artery stenosis due to cerebral vasculopathy related to neurofibromatosis (NF1).Thoracic aortic disease in tuberous sclerosis complex: molecular pathogenesis and potential therapies in Tsc2+/- mice.Disrupted nitric oxide signaling due to GUCY1A3 mutations increases risk for moyamoya disease, achalasia and hypertension.Young stroke due to vascular anomaly from neurofibromatosis type 1.
P2860
Q26800801-335D36E8-BFC1-4D81-A516-CC31ADA5572AQ26865241-4FA78040-BCD6-4887-B0FE-659E31836A7FQ28080728-E1F2302A-4C54-48FF-A08D-14A855713C18Q28086795-13A11326-7E33-42FF-A822-AD18DBA2C3C9Q28593384-E26FBFBD-8BB9-4040-BF6C-BE7F6B22EED6Q30706016-0E7F7204-186D-44A6-8C0B-09FC5F0CD951Q31112180-EA42E7FA-729C-47E8-9878-23E68155F7A6Q33437733-3CAE7CA2-E30C-43C1-8520-6CC6C65A5001Q33685670-3F59F23A-3F0E-495C-A3A3-B5665AE202A6Q33757823-3EA2CC7E-4F3F-45E5-9B95-4479AFB93637Q33925617-1E8FAAC8-7231-4EF3-89DB-6456178CF0BBQ35571989-D630C4E5-2CFF-4590-86E0-46FB06F6903BQ35896681-B66BC796-1EA8-4B12-A289-B5432E29A284Q36380195-6B9D0043-653E-4628-A377-E159DA6BC5FAQ36395077-D8B4D7C7-4B05-4923-8590-D351574A16B4Q36668971-C029BF80-0A0B-41B2-A658-F9A8F6C54DE8Q36815366-E0724A00-E6AA-4D08-9604-76A4E49AEF9BQ36853643-A23CBBF8-CB3D-463D-9FCD-C41519D7EB62Q36884734-5C51E432-61D9-4426-A977-038F32561D1DQ36921338-0FD71539-20A5-47C6-BF7D-AEF05D213C31Q37391278-B6CA24A5-BDAD-4E92-941E-383F13A73B94Q37393469-F7FADF75-453A-45D6-9CB9-F79DA2120F28Q37459664-1929CB7B-EE70-4771-A7E3-41550234137EQ37514623-0328CF76-4BB5-473A-9450-44B84826FA9BQ37590444-48012AD9-05F6-4164-AEAB-3BCABA500FB3Q37601496-B6FE0DEA-D2FD-4EDE-A770-A8C10A7C29D2Q37649834-D154FCA1-7C7E-4960-8DA5-460BF1181928Q37687053-C17C2F47-3B15-4400-A988-1DAF7ECFE729Q37876088-7B8F4D1B-E5AF-479B-9C8A-6A659684B94EQ38832500-EFB0A064-794C-44F8-8596-C890B7372820Q39064991-3F1F7EA1-B1FF-47E7-B402-7D1795576ABBQ39100045-63BF078D-3711-418A-BFEB-48ED3A229383Q39707123-9303B778-7E4C-4AF0-AF57-3D8DDD5FB677Q39849752-17AD0900-5558-4E2B-8AF7-9552FB670426Q39907397-B3EA79E0-D2C7-41EB-8CD4-1EE7806D2A2DQ40077902-514531DB-9E84-4321-AA62-240FE77A69E9Q40199840-35A35A0A-08C3-4366-8722-81312CC0A578Q40237430-8FEF9519-A206-496E-A1B7-658FD2D60248Q41637594-E6D044EC-47AB-4F4D-A90E-F20928350AA1Q41867900-1BDADEB3-CA4C-4EBA-8C3F-9836725BE721
P2860
Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1.
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1.
@ast
Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1.
@en
type
label
Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1.
@ast
Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1.
@en
prefLabel
Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1.
@ast
Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1.
@en
P2093
P1433
P1476
Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1.
@en
P2093
Gilbert Vezina
Roger J Packer
Tena L Rosser
P304
P356
10.1212/01.WNL.0000150544.00016.69
P407
P577
2005-02-01T00:00:00Z